Navigation Links
Hard To Treat Diseases (HTDS) Recapitalization
Date:1/9/2009

BELGRADE, Serbia, Jan. 9 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com the company having recently completed a merger with Slavica Bio Chem (Formerly ReNuYu Biochem) intends to recapitalize to 5 billion shares to pay for the Slavica merger and the pending China Bio Chem merger. Consideration for Slavica is 300 million non-dilatable restricted shares to be distributed amongst all doctors involved in Belgrade Serbia research. Key medical consultants and X ReNuYu management will receive stock options at a .03c strike price for up to 9% of the company common stock.

At present the company stock formulation details are as follows: Number of Common Shares Authorized: 1,200,000,000. Number of Common Shares Outstanding 862,581,959. Number of Restricted Shares: 480,091,291 Number of Preferred Shares Authorized: 25,000,000. Number of Preferred Shares Issued: None. The company intends to issue 10,000 convertible preferred shares to secure debt financing of about 1.5 million dollars.

The company's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. Other interests include an on line cosmetics company.

The company will provide further details as they become available.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at azconsulting2001@gmail.com. For any corporate matters the readers should contact the company directly at corporate@htdsmedical.com

CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at azconsulting2001@gmail.com. For any corporate matters the readers should contact the company directly at corporate@htdsmedical.com


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Study Finds More Effective Treatment for Pneumonia Following Influenza
2. Study finds more effective treatment for pneumonia following influenza
3. Identification of genetic markers for ulcerative colitis could lead to treatment
4. Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
5. Hard To Treat Diseases (HTDS) Set To Acquire Cosmetics Company
6. Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
7. Kawasaki Disease Treated with Plasma-Derived Therapy
8. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
9. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
10. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
11. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ODU, a ... the US market its advanced highly customizable contact technology solutions. , ODU Single ... advanced technologies are ideal for a wide range of applications that require customization ...
(Date:12/7/2016)... ... , ... One of two inventors from Glen Burnie, Md., has a granddaughter ... "This is why the co-inventor and I have designed a new and better way ... prototype of the patent-pending AV-AIR, a device that serves as an alternative to conventional ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Sharon Kleyne, ... Global Climate Change and Your Health on Voice of America, declared on her radio ... call attention to the fact that when these bullies attack leaders in corporate America, ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... is condemning "scam operations" carried out by unethical locksmith companies and is urging ... to a halt. According to Texas Premier Locksmith, these fraudulent locksmith services take ...
(Date:12/7/2016)... ... 2016 , ... Gensuite is honored to be selected as ... Product Launch category. Gensuite’s entry on their EZ Scan feature detailed the tool’s ... Training Group is a professional event and training provider based in the United ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Boehringer Ingelheim today announced that the ... malignant pleural mesothelioma (MPM) met its primary endpoint ... the 17 th IASLC World Conference on ... showed nintedanib plus pemetrexed/cisplatin demonstrated a meaningful clinical ... significantly improved PFS (9.4 vs 5.7 months). Preliminary ...
(Date:12/7/2016)... 7, 2016 According to the ... Global Market Study on Multiplex Detection Immunoassay: North America ... the global multiplex detection immunoassay market is expected to witness a ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
(Date:12/6/2016)... , Dec. 6, 2016  "Blood Tests replace ... announced ....." The Diagnostic, Monitoring and Screening ... cancer diagnostics is occurring using in vitro blood ... company with impressive backing, has announced a single ... is moving faster than the market. New technology ...
Breaking Medicine Technology: